KXNT_35x90 cbssports1140-horizontal-small

News

Jury Rules In Favor of Drug-Maker in Actos Trial

View Comments
Getty Images-483340575

Getty Images-483340575

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

(LAS VEGAS, KXNT)–A jury has ruled in favor of the Japanese drug-maker Takeda in a trial in which two elderly Las Vegas-area women sued the company, alleging its diabetes drug Actos caused their bladder cancer.

The women filed separate actions alleging Takeda failed to convey information about a cancer risk to those taking the popular medication.

Takeda said during the course of a trial in Las Vegas that 70,000 people develop bladder cancer annually.

In 2011, the Food and Drug Administration issued a safety warning that use of Actos for more than one year could be associated with an increased risk of bladder cancer.

Takeda has prevailed in four of five similar lawsuits brought in the past. The drug has been sold in the U.S. since 1999.

Bertha Triana, and Delores Cipriano had sued the company. Both were diagnosed with bladder cancer in 2012.

Cipriano was represented by noted Las Vegas attorney Robert Eglet, who has won major damage awards in the past in connection with the Hepatitis C outbreak in the Valley in 2007.

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 1,007 other followers